We are live on ! Find out more
TA

Tamarack Advisers Portfolio holdings

AUM $2.12M
1-Year Est. Return 58.09%
This Fund
S&P 500
This Quarter Est. Return
+11.89%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
–
AUM
$318M
AUM Growth
+$57.2M
Cap. Flow
+$31.1M
Cap. Flow %
9.77%
Top 10 Hldgs %
65.15%
Holding
46
New
18
Increased
7
Reduced
10
Closed
9

Top Buys

Rank Stock Value
1
PDCO
Patterson Companies, Inc.
PDCO
+$25.6M
2
WBA
Walgreens Boots Alliance
WBA
+$16.3M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$13.5M
4
PCRX icon
Pacira BioSciences
PCRX
+$8.23M
5
CORV
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
+$8.02M

Top Sells

Rank Stock Value
1
IMPR
IMPRIVATA, INC COM
IMPR
+$18.3M
2
DGX icon
Quest Diagnostics
DGX
+$14.7M
3
LH icon
Labcorp
LH
+$9.77M
4
NVRO
NEVRO CORP.
NVRO
+$6.06M
5
DXCM icon
DexCom
DXCM
+$5.16M

Sector Composition

Rank Sector Weight
1 Healthcare 96.3%
2 Miscellaneous 2%
3 Communication Services 1.14%
4 Real Estate 0.56%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRT
26
DELISTED
MedEquities Realty Trust, Inc.
MRT
$1.77M 0.56%
+150,000
New +$1.75M
GKOS icon
27
Glaukos
GKOS
$10.5B
$1.72M 0.54%
+45,000
New +$1.49M
ATHN
28
CALL
DELISTED
Athenahealth, Inc.
ATHN
$1.67M 0.52%
+900
New +$114K
ENDP
29
DELISTED
Endo International plc
ENDP
$1.52M 0.48%
+75,000
New +$1.49M
DGX icon
30
Quest Diagnostics
DGX
$26.2B
$716K 0.23%
8,557
-174,900
-95% -$14.7M
BSX icon
31
PUT
Boston Scientific
BSX
$69.3B
$533K 0.17%
+3,500
New +$83.5K
SPY icon
32
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
$520K 0.16%
+5,000
New +$1.08M
OEF icon
33
PUT
iShares S&P 100 ETF
OEF
$20.5B
$372K 0.12%
+3,000
New +$288K
INSY
34
CALL
DELISTED
Insys Therapeutics, Inc.
INSY
$366K 0.12%
+2,010
New +$30.6K
XLV icon
35
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$44.1B
$253K 0.08%
+1,000
New +$73.6K
LNTH icon
36
Lantheus
LNTH
$6.59B
$226K 0.07%
+28,047
New +$186K
AMRN
37
Amarin Corp
AMRN
$288M
– –
-90,000
Closed -$3.89M
COLL icon
38
Collegium Pharmaceutical
COLL
$766M
– –
-94,908
Closed -$1.13M
DXCM icon
39
DexCom
DXCM
$33.2B
– –
-260,000
Closed -$5.16M
LH icon
40
Labcorp
LH
$26.5B
– –
-87,300
Closed -$9.77M
SPY icon
41
State Street SPDR S&P 500 ETF Trust
SPY
$815B
– –
-3,000
Closed -$648K
NVRO
42
DELISTED
NEVRO CORP.
NVRO
– –
-82,200
Closed -$6.06M
IMPR
43
DELISTED
IMPRIVATA, INC COM
IMPR
– –
-1,309,800
Closed -$18.3M
RLYP
44
DELISTED
RELYPSA INC COM
RLYP
– –
-94,475
Closed -$1.75M
SGNT
45
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
– –
-259,336
Closed -$3.88M
1
2

Similar funds

SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
LBC
Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
STC
Sarah T. Connolly $1.11M AUM 24.13% 1-Year Est. Return
GC
Gilfoyle & Co San Francisco, California $671K AUM
DU
Delphia (USA) Toronto, Ontario, Canada $445K AUM 28.82% 1-Year Est. Return

Tamarack Advisers's Q3 2016 Portfolio in Review

As of Q3 2016, Tamarack Advisers held 46 positions worth $318M, up 22% from $261M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Tamarack Advisers deployed $31.1M of net new capital in Q3 2016, opening 18 new positions and adding to 7 existing holdings. Its largest new stake was Walgreens Boots Alliance: 200,000 shares worth $16M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 90% a quarter earlier, followed by Miscellaneous and Communication Services.

On the sell side, the largest reduction was Quest Diagnostics, an estimated $14.7M trimmed.

  • Tamarack Advisers's largest Q3 2016 buy was Walgreens Boots Alliance: 200,000 shares worth $16M.
  • Tamarack Advisers added most to Patterson Companies, Inc. in Q3 2016, an estimated $25.6M increase.
  • Tamarack Advisers's biggest Q3 2016 reduction was Quest Diagnostics, cutting an estimated $14.7M.
  • Tamarack Advisers fully exited IMPRIVATA, INC COM in Q3 2016, selling an estimated $18.3M.
  • Tamarack Advisers's ten largest holdings make up 65% of its $318M portfolio in Q3 2016.
  • Tamarack Advisers opened 18 new positions and closed 9 in Q3 2016.
  • Tamarack Advisers's portfolio value rose 22% quarter-over-quarter to $318M.

Based on Tamarack Advisers's 13F filing for Q3 2016, filed 9 Nov 2016.